Literature DB >> 19658090

Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants.

Ben M Illigens1, Akira Yamada, Natalie Anosova, Victor M Dong, Mohamed H Sayegh, Gilles Benichou.   

Abstract

The contribution of direct and indirect alloresponses by CD4(+) Th1 and Th2 cells in acute and chronic rejection of allogeneic transplants remains unclear. In the present study, we addressed this question using a transplant model in a single MHC class I-disparate donor-recipient mouse combination. BALB/c-dm2 (dm2) mutant mice do not express MHC class I L(d) molecules and reject acutely L(d+) skin grafts from BALB/c mice. In contrast, BALB/c hearts placed in dm2 mice are permanently accepted in the absence of chronic allograft vasculopathy. In this model, CD4(+) T cells are activated following recognition of a donor MHC class I determinant, L(d) 61-80, presented by MHC Class II A(d) molecules on donor and recipient APC. Pre-transplantation of recipients with L(d) 61-80 peptide emulsified in complete Freund's adjuvant induced a Th1 response, which accelerated the rejection of skin allografts, but it had no effect on cardiac transplants. In contrast, induction of a Th2 response to the same peptide abrogated the CD8(+) cytotoxic T cells response and markedly delayed the rejection of skin allografts while it induced de novo chronic rejection of heart transplants. This shows that Th2 cells activated via indirect allorecognition can exert dual effects on acute and chronic rejection of allogeneic transplants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19658090      PMCID: PMC2911804          DOI: 10.1002/eji.200838980

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  58 in total

1.  Why do we reject a graft? Role of indirect allorecognition in graft rejection.

Authors:  M H Sayegh
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

2.  Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.

Authors:  M A Williams; J Trambley; J Ha; A B Adams; M M Durham; P Rees; S R Cowan; T C Pearson; C P Larsen
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

3.  Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant.

Authors:  P S Heeger; T Forsthuber; C Shive; E Biekert; C Genain; H H Hofstetter; A Karulin; P V Lehmann
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

4.  Induction of T-cell response to cryptic MHC determinants during allograft rejection.

Authors:  F Boisgérault; N G Anosova; R C Tam; B M Illigens; E V Fedoseyeva; G Benichou
Journal:  Hum Immunol       Date:  2000-12       Impact factor: 2.850

5.  Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy.

Authors:  R S Lee; K Yamada; S L Houser; K L Womer; M E Maloney; H S Rose; M H Sayegh; J C Madsen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

6.  Induction of TH1 and TH2 immunity in neonatal mice.

Authors:  T Forsthuber; H C Yip; P V Lehmann
Journal:  Science       Date:  1996-03-22       Impact factor: 47.728

7.  Two levels of help for B cell alloantibody production.

Authors:  D J Steele; T M Laufer; S T Smiley; Y Ando; M J Grusby; L H Glimcher; H Auchincloss
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

8.  Direct evidence for in vivo induction of CD8+ cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation.

Authors:  I A Popov; E V Fedoseyeva; P L Orr; M R Garovoy; G Benichou
Journal:  Transplantation       Date:  1995-12-27       Impact factor: 4.939

9.  Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.

Authors:  M E Russell; W W Hancock; E Akalin; A F Wallace; T Glysing-Jensen; T A Willett; M H Sayegh
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

10.  Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.

Authors:  E V Fedoseyeva; R C Tam; P L Orr; M R Garovoy; G Benichou
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  12 in total

1.  Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates.

Authors:  Ognjenka Nadazdin; Svjetlan Boskovic; Siew-Lin Wee; Hiroshi Sogawa; Ichiro Koyama; Robert B Colvin; R Neal Smith; Georges Tocco; David H O'Connor; Julie A Karl; Joren C Madsen; David H Sachs; Tatsuo Kawai; A Benedict Cosimi; Gilles Benichou
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

Review 2.  Monitoring alloimmune response in kidney transplantation.

Authors:  Oriol Bestard; Paolo Cravedi
Journal:  J Nephrol       Date:  2016-05-31       Impact factor: 3.902

3.  Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant Recipients.

Authors:  Jong Man Kim; Choon Hyuck David Kwon; Jae-Won Joh; Dong Hyun Sinn; Gyu-Seong Choi; Jae Berm Park; Eun-Suk Kang; Suk-Koo Lee
Journal:  Med Princ Pract       Date:  2017-01-09       Impact factor: 1.927

4.  Primary vascularization of allografts governs their immunogenicity and susceptibility to tolerogenesis.

Authors:  Cavit D Kant; Yoshinobu Akiyama; Katsunori Tanaka; Susan Shea; Sarah E Connolly; Sharon Germana; Henry J Winn; Christian LeGuern; Georges Tocco; Gilles Benichou
Journal:  J Immunol       Date:  2013-07-05       Impact factor: 5.422

Review 5.  Immunotherapy with myeloid cells for tolerance induction.

Authors:  Mercedes Rodriguez-García; Peter Boros; Jonathan S Bromberg; Jordi C Ochando
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

6.  Both rejection and tolerance of allografts can occur in the absence of secondary lymphoid tissues.

Authors:  Cavit D Kant; Yoshinobu Akiyama; Katsunori Tanaka; Susan Shea; Yohei Yamada; Sarah E Connolly; Jose Marino; Georges Tocco; Gilles Benichou
Journal:  J Immunol       Date:  2014-12-22       Impact factor: 5.422

Review 7.  Chronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens.

Authors:  Vijay Subramanian; Thalachallour Mohanakumar
Journal:  Expert Rev Clin Immunol       Date:  2012-09       Impact factor: 4.473

Review 8.  Antihuman leukocyte antigen antibody-induced autoimmunity: role in chronic rejection.

Authors:  Dilip S Nath; Haseeb Illias Basha; Thalachallour Mohanakumar
Journal:  Curr Opin Organ Transplant       Date:  2010-02       Impact factor: 2.640

9.  Host-based Th2 cell therapy for prolongation of cardiac allograft viability.

Authors:  Shoba Amarnath; Hao Chen; Jason E Foley; Carliann M Costanzo; Joel D Sennesh; Michael A Solomon; Daniel H Fowler
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

10.  Innate immunity and resistance to tolerogenesis in allotransplantation.

Authors:  Gilles Benichou; Makoto Tonsho; Georges Tocco; Ognjenka Nadazdin; Joren C Madsen
Journal:  Front Immunol       Date:  2012-04-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.